Deubiquitylation and stabilization of PTEN by USP13

Nature Cell Biology

Volumn 15, Issue 12, 2013, Pages 1486-1494

  Zhang, Jinsong ^a   Zhang, Peijing ^a   Wei, Yongkun ^a   Piao, Hai Long ^a   Wang, Wenqi ^a   Maddika, Subbareddy ^b   Wang, Min ^a   Chen, Dahu ^a   Sun, Yutong ^a   Hung, Mien Chie ^a,c,d   Chen, Junjie ^a,c   Ma, Li ^a,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

^c UNIVERSITY OF TEXAS   (United States)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEINASE; PTEN PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; USP13 PROTEIN, HUMAN;

ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENETICS; GLYCOLYSIS; HEK293 CELL LINE; HUMAN; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PROTEIN STABILITY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR VOLUME; UBIQUITINATION; ARTICLE; CELL STRAIN HEK293;

ANIMALS; BREAST NEOPLASMS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOPEPTIDASES; FEMALE; GENE EXPRESSION; GLYCOLYSIS; HEK293 CELLS; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROTEIN STABILITY; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEINS; UBIQUITINATION;

EID: 84893378525     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2874     Document Type: Article

References (38)

1. Leevers, S. J., Vanhaesebroeck, B. & Waterfield, M. D. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr. Opin. Cell Biol. 11, 219–225 (1999).
2. Maehama, T. & Dixon, J. E. The tumour suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate. J. Biol. Chem. 273, 13375–13378 (1998).
3. Di Cristofano, A., Pesce, B., Cordon-Cardo, C. & Pandolfi, P. P. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19, 348–355 (1998).
4. Garcia-Cao, I. et al. Systemic elevation of PTEN induces a tumour-suppressive metabolic state. Cell 149, 49–62 (2012).
5. Song, M. S., Salmena, L. & Pandolfi, P. P. The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 13, 283–296 (2012).
6. Liaw, D. et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16, 64–67 (1997).
7. Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943–1947 (1997).
8. Steck, P. A. et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15, 356–362 (1997).
9. Hollander, M. C., Blumenthal, G. M. & Dennis, P. A. PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat. Rev. Cancer 11, 289–301 (2011).
10. Shi, Y., Paluch, B. E., Wang, X. & Jiang, X. PTEN at a glance. J. Cell Sci. 125, 4687–4692 (2012).
11. Wang, X. & Jiang, X. Post-translational regulation of PTEN. Oncogene 27, 5454–5463 (2008).
12. Fata, J. E., Debnath, S., Jenkins, E. C. Jr. & Fournier, M. V. Nongenomic mechanisms of PTEN regulation. Int. J. Cell Biol. 2012, 379685 (2012).
13. Trotman, L. C. et al. Ubiquitination regulates PTEN nuclear import and tumour suppression. Cell 128, 141–156 (2007).
14. Wang, X. et al. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 128, 129–139 (2007).
15. Maddika, S. et al. WWP2 is an E3 ubiquitin ligase for PTEN. Nat. Cell Biol. 13, 728–733 (2011).
16. Van Themsche, C., Leblanc, V., Parent, S. & Asselin, E. X-linked inhibitor of apoptosis protein (XIAP) regulates PTEN ubiquitination, content, and compartmentalization. J. Biol. Chem. 284, 20462–20466 (2009).
17. Ahmed, S.F. et al. The chaperone-assisted E3 ligase C terminus of Hsc70-interacting protein (CHIP) targets PTEN for proteasomal degradation. J. Biol. Chem. 287, 15996–16006 (2012).
18. Song, M. S. et al. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 455, 813–817 (2008).
19. Wilkinson, K. D. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J. 11, 1245–1256 (1997).
20. Weigelt, B., Warne, P. H. & Downward, J. PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs. Oncogene 30, 3222–3233 (2011).
21. Hollestelle, A., Elstrodt, F., Nagel, J. H., Kallemeijn, W. W. & Schutte, M. Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines. Mol. Cancer Res. 5, 195–201 (2007).
22. Zhao, X., Fiske, B., Kawakami, A., Li, J. & Fisher, D. E. Regulation of MITF stability by the USP13 deubiquitinase. Nat. Commun. 2, 414 (2011).
23. Song, M. S. et al. Nuclear PTEN regulates the APC-CDH1 tumour-suppressive complex in a phosphatase-independent manner. Cell 144, 187–199 (2011).
24. Lee, J. O. et al. Crystal structure of the PTEN tumour suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99, 323–334 (1999).
25. Elstrom, R. L. et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 64, 3892–3899 (2004).
26. Manning, B. D. & Cantley, L. C. AKT/PKB signalling: navigating downstream. Cell 129, 1261–1274 (2007).
27. Warburg, O. On the origin of cancer cells. Science 123, 309–314 (1956).
28. Gustafson, S., Zbuk, K. M., Scacheri, C. & Eng, C. Cowden syndrome. Semin. Oncol. 34, 428–434 (2007).
29. Alimonti, A. et al. Subtle variations in Pten dose determine cancer susceptibility. Nat. Genet. 42, 454–458 (2010).
30. Perez-Tenorio, G. et al. PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer. Clin. Cancer Res. 13, 3577–3584 (2007).
31. Chen, D. et al. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nat. Med. 18, 1511–1517 (2012).
32. Yuan, J., Luo, K., Zhang, L., Cheville, J. C. & Lou, Z. USP10 regulates p53 localization and stability by deubiquitinating p53. Cell 140, 384–396 (2010).
33. Giaccia, A. J. & Kastan, M. B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes. Dev. 12, 2973–2983 (1998).
34. Salmena, L., Carracedo, A. & Pandolfi, P. P. Tenets of PTEN tumour suppression. Cell 133, 403–414 (2008).
35. Lee, C., Kim, J.S. & Waldman, T. PTEN gene targeting reveals a radiation-induced size checkpoint in human cancer cells. Cancer Res. 64, 6906–6914 (2004).
36. Kim, J. S., Lee, C., Bonifant, C. L., Ressom, H. & Waldman, T. Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA. Mol. Cell Biol. 27, 662–677 (2007).
37. Shevchenko, A., Wilm, M., Vorm, O. & Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68, 850–858 (1996).
38. Elias, J. E. & Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207–214 (2007)